Genfit Competitors and Similar CompaniesClear all
Genfit's competitors and similar companies include Ablynx and Esperite.
 Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ||
Founding Date | Founding Date 1999 | Founding Date 2001 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Loos, FR HQ Cambridge, US | Locations Gent, BE HQ | Locations Amsterdam, NL HQ Villeurbanne, FR |
Employees | Employees 180 | Employees 1252% decrease | Employees 133 |
Valuation ($) | Valuation ($) 280.8 m | Valuation ($) N/A | Valuation ($) 38.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) €11.8m (FY, 2018) |
Cost of goods | Cost of goods €302k (FY, 2025) | Cost of goods N/A | Cost of goods €4.3m (FY, 2018) |
Gross profit | Gross profit €70.8m (FY, 2025) | Gross profit N/A | Gross profit €7.5m (FY, 2018) |
Net income | Net income (€86m) (FY, 2025) | Net income (€1.1m) (FY, 2016) | Net income (€18.5m) (FY, 2018) |
Operating ⚠ | |||
Patents (Foreign) | Patents (Foreign) 450 (FY, 2019) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) N/A |
Patents (US) | Patents (US) 28 (FY, 2019) | Patents (US) 50 (Q2, 2017) | Patents (US) N/A |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company
Esperite
HQ
Amsterdam, NL
Employees
133
Esperite is a company specializing in regenerative and predictive medicine.
View company